Israel China Biotechnology (ICB) Ltd (ICB) — Tangible Net Worth Ratio
Israel China Biotechnology (ICB) Ltd (ICB) has a Tangible Net Worth Ratio of 100.0% as of June 2021. This metric is calculated by deducting intangible assets (ILA0.00) from net assets (ILA2.55 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Israel China Biotechnology (ICB) Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Israel China Biotechnology (ICB) Ltd Tangible Net Worth Ratio (2015–2020)
This chart shows how Israel China Biotechnology (ICB) Ltd's Tangible Net Worth Ratio has changed across 5 annual periods from 2015 to 2020. As of June 2021, the ratio stands at 100.0%, reflecting net assets of ILA2.55 Million with intangible assets of ILA0.00 ILA. For live market cap and overall valuation, see Israel China Biotechnology (ICB) Ltd (ICB) total market value.
Annual Tangible Net Worth Ratio for Israel China Biotechnology (ICB) Ltd (2015–2020)
The table below presents the year-by-year Tangible Net Worth Ratio for Israel China Biotechnology (ICB) Ltd from 2015 to 2020, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See Israel China Biotechnology (ICB) Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2020 | 100.0% | ILA470.00K | ILA0.00 | ILA8.34 Million | ▲ +0.0 pp |
| 2019 | 100.0% | ILA1.89 Million | ILA0.00 | ILA11.57 Million | ▲ +0.0 pp |
| 2018 | 100.0% | ILA7.41 Million | ILA0.00 | ILA9.88 Million | ▲ +16.9 pp |
| 2016 | 83.1% | ILA1.91 Million | ILA322.00K | ILA4.06 Million | ▼ -16.9 pp |
| 2015 | 100.0% | ILA5.78 Million | ILA0.00 | ILA8.18 Million | — |